logo
Trump administration blocks CDC health programmes funding — WSJ

Trump administration blocks CDC health programmes funding — WSJ

TimesLIVE04-08-2025
US President Donald Trump's administration is blocking funding for a swath of public health programmes run by the Centers for Disease Control and Prevention (CDC), the Wall Street Journal (WSJ) reported on Friday, citing unnamed sources.
These include youth violence prevention programmes, research on preventing gun injuries and deaths and efforts targeting diabetes, chronic kidney disease and tobacco use, according to the report.
The money withheld could not be determined, but it could be up to $200m (R3.59bn), the WSJ reported, citing a person familiar with the matter.
The CDC did not immediately respond to a Reuters request for comment.
The White House has previously stated its intention to reduce US health spending by more than a quarter next year, with the National Institutes of Health and the CDC facing the brunt of billions of dollars in cuts.
Earlier this week, Susan Monarez was confirmed as CDC director to lead a downsized agency as the White House moves to slash its budget by nearly $3.6bn (R64.73bn), reducing it to about (R71.94bn).
The cuts follow a layoff plan enacted by US health secretary Robert F Kennedy Jnr that eliminated 2,400 positions in the CDC, though about 700 of those workers have since been rehired.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US axes mRNA vaccine contracts, casting safety doubts
US axes mRNA vaccine contracts, casting safety doubts

Eyewitness News

time06-08-2025

  • Eyewitness News

US axes mRNA vaccine contracts, casting safety doubts

WASHINGTON - President Donald Trump's administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines, questioning the safety of a technology credited with helping end the Covid pandemic and saving millions of lives. The announcement, made by Health Secretary Robert F. Kennedy Jr., marks his latest effort to weave vaccine scepticism into the core of US government policy. "We reviewed the science, listened to the experts, and acted," Kennedy said in a statement. The health department's Biomedical Advanced Research and Development Authority (BARDA) is "terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu," he added. "We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate." The changes affect Moderna's mRNA bird flu vaccine - a move the company itself disclosed in May - as well as numerous other programs, including "rejection or cancellation of multiple pre-award solicitations" from pharmaceutical giants Pfizer and Sanofi. In total, the affected projects are worth "nearly $500 million," the Department of Health and Human Services (HHS) said. Certain late-stage projects were excluded from the move "to preserve prior taxpayer investment." "Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them," Secretary Kennedy said. "That's why we're moving beyond the limitations of mRNA and investing in better solutions." Since taking office, Kennedy, who spent two decades sowing misinformation around immunisation, has overseen a major overhaul of US health policy - firing, for example, a panel of vaccine experts that advise the government and replacing them with his own appointees. In its first meeting, the new panel promptly voted to ban a longstanding vaccine preservative targeted by the anti-vaccine movement, despite its strong safety record. He has also ordered a sweeping new study on the long-debunked link between vaccines and autism. Unlike traditional vaccines, which often use weakened or inactivated forms of the target virus or bacteria, mRNA shots deliver genetic instructions into the host's cells, prompting them to produce a harmless decoy of the pathogen and train the immune system to fight the real thing. Though in development for decades, mRNA vaccines were propelled from lab benches to widespread use through President Trump's Operation Warp Speed - a public-private partnership led by BARDA that poured billions into companies to accelerate development. The technology's pioneers, Katalin Kariko and Drew Weissman, were awarded the 2023 Nobel Prize in Medicine for their work contributing "to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times."

Trump administration blocks CDC health programmes funding — WSJ
Trump administration blocks CDC health programmes funding — WSJ

TimesLIVE

time04-08-2025

  • TimesLIVE

Trump administration blocks CDC health programmes funding — WSJ

US President Donald Trump's administration is blocking funding for a swath of public health programmes run by the Centers for Disease Control and Prevention (CDC), the Wall Street Journal (WSJ) reported on Friday, citing unnamed sources. These include youth violence prevention programmes, research on preventing gun injuries and deaths and efforts targeting diabetes, chronic kidney disease and tobacco use, according to the report. The money withheld could not be determined, but it could be up to $200m (R3.59bn), the WSJ reported, citing a person familiar with the matter. The CDC did not immediately respond to a Reuters request for comment. The White House has previously stated its intention to reduce US health spending by more than a quarter next year, with the National Institutes of Health and the CDC facing the brunt of billions of dollars in cuts. Earlier this week, Susan Monarez was confirmed as CDC director to lead a downsized agency as the White House moves to slash its budget by nearly $3.6bn (R64.73bn), reducing it to about (R71.94bn). The cuts follow a layoff plan enacted by US health secretary Robert F Kennedy Jnr that eliminated 2,400 positions in the CDC, though about 700 of those workers have since been rehired.

US considers travel notice for China as chikungunya cases rise: Bloomberg
US considers travel notice for China as chikungunya cases rise: Bloomberg

TimesLIVE

time31-07-2025

  • TimesLIVE

US considers travel notice for China as chikungunya cases rise: Bloomberg

The US Centers for Disease Control and Prevention (CDC) is planning to issue a travel notice for China as mosquito-borne chikungunya infections rise in the country, Bloomberg News reported on Wednesday. 'CDC is aware of the reported chikungunya outbreak in Guangdong province in China and is assessing the size and extent of the outbreak,' a CDC spokesperson told Bloomberg News. The CDC did not immediately respond to a Reuters request for comment. According to the Global Times newspaper, south China's Guangdong province reported 4,824 chikungunya cases by July 26. Chikungunya, which is spread primarily by Aedes mosquito species and has no specific treatment, can cause rapid and large outbreaks. As the mosquitoes bite in the daytime, prevention is key through the use of insect repellent and long-sleeved clothing. Earlier this month, the World Health Organisation issued an urgent call for action to prevent a repeat of the 2004-2005 epidemic of chikungunya as new outbreaks linked to the Indian Ocean region spread to Europe and other continents. The latest surge began in early 2025, with major outbreaks in the same Indian Ocean islands previously hit, including La Reunion, Mayotte and Mauritius.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store